Table 3. Origin and frequency of Staphylococcus aureus isolates according to their sequence typesa.
| Sequence type | Present study | Data from the MLST Web site | ||||
|---|---|---|---|---|---|---|
|
|
Country of origin of CA-MRSA |
n |
Country of origin of MSSA |
n |
Country of origin of MRSA |
n |
| 1 |
USA |
29 |
UK, Denmark, the Netherlands, Canada, |
20 |
|
0 |
| 8 |
USA |
3 |
UK, the Netherlands, Denmark, US, Canada |
46 |
Scotland, Ireland, Australia, U.S., UK, Germany, The Netherlands, France |
39 |
| 30 |
Oceania (Southwest Pacific clone) |
13 |
UK, Denmark, Germany |
83 |
UK, Spain, Germany,
Sweden |
8 |
| 59 |
USA |
1 |
UK |
4 |
U.S. |
1 |
| 80 |
France, Switzerland |
67 |
|
0 |
Greece |
1 |
| 93 | Australia (Queensland clone) | 4 | 0 | 0 | ||
aMLST, multi-locus sequence typing ; MRSA, methicillin resistant S. aureus; MSSA, methicillin-susceptible S. aureus; CA, community acquired.